Procept preclinical data

PRCT (Cambridge, Mass.) presented cell culture data on the ability of PRO 2000 to inhibit infection by different isolates of HIV.

As reported at the Keystone Symposia on HIV Pathogenesis, the compound blocked binding of gp120, an HIV surface protein, at its docking site at the CD4 receptor on immune cells. ...